Literature DB >> 33377638

Overexpression of miR-483-5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma.

Luis Jaime Castro-Vega1, Bruna Calsina2, Nelly Burnichon1,3, Tom Drossart1,3, Ángel M Martínez-Montes2, Virginie Verkarre1,4, Laurence Amar1,5, Jérôme Bertherat6,7, Cristina Rodríguez-Antona2,8, Judith Favier1, Mercedes Robledo2,8, Anne-Paule Gimenez-Roqueplo1,3,7.   

Abstract

Entities:  

Year:  2020        PMID： 33377638      PMCID： PMC7752161          DOI： 10.1002/ctm2.260

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN： 2001-1326


× No keyword cloud information.
  12 in total

1.  miR-483-3p controls proliferation in wounded epithelial cells.

Authors:  Thomas Bertero; Cécile Gastaldi; Isabelle Bourget-Ponzio; Véronique Imbert; Agnès Loubat; Eric Selva; Roser Busca; Bernard Mari; Paul Hofman; Pascal Barbry; Guerrino Meneguzzi; Gilles Ponzio; Roger Rezzonico
Journal:  FASEB J       Date:  2011-06-15       Impact factor: 5.191

2.  MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.

Authors:  Goswin Y Meyer-Rochow; Nicole E Jackson; John V Conaglen; Denis E Whittle; Muthusamy Kunnimalaiyaan; Herbert Chen; Gunnar Westin; Johanna Sandgren; Peter Stålberg; Elham Khanafshar; Daniel Shibru; Quan-Yang Duh; Orlo H Clark; Electron Kebebew; Anthony J Gill; Rory Clifton-Bligh; Bruce G Robinson; Diana E Benn; Stan B Sidhu
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

3.  The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.

Authors:  E Patterson; R Webb; A Weisbrod; B Bian; M He; L Zhang; A K Holloway; R Krishna; N Nilubol; K Pacak; E Kebebew
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

4.  MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.

Authors:  Samantha M Ruff; Reed I Ayabe; Parisa Malekzadeh; Meghan L Good; Michael M Wach; Melissa K Gonzales; Amit Tirosh; Naris Nilubol; Karel Pacak; Electron Kebebew; Dhaval Patel
Journal:  J Surg Res       Date:  2019-05-27       Impact factor: 2.192

Review 5.  Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.

Authors:  Ariana von Lersner; Lenny Droesen; Andries Zijlstra
Journal:  Clin Exp Metastasis       Date:  2019-02-18       Impact factor: 5.150

6.  MiR-483-5p controls angiogenesis in vitro and targets serum response factor.

Authors:  Yu Qiao; Ning Ma; Xidi Wang; Yang Hui; Fuyuan Li; Ying Xiang; Jianying Zhou; Chaoxia Zou; Jianfeng Jin; Guixiang Lv; Hongbo Jin; Xu Gao
Journal:  FEBS Lett       Date:  2011-09-01       Impact factor: 4.124

7.  HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop.

Authors:  Patricia L M Dahia; Roderick Clifton-Bligh; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo; Camilo Jimenez
Journal:  Endocr Relat Cancer       Date:  2020-08       Impact factor: 5.678

8.  Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.

Authors:  V H M Tsang; T Dwight; D E Benn; G Y Meyer-Rochow; A J Gill; M Sywak; S Sidhu; D Veivers; C M Sue; B G Robinson; R J Clifton-Bligh; N R Parker
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

9.  Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.

Authors:  Bruna Calsina; Luis Jaime Castro-Vega; Rafael Torres-Pérez; Lucía Inglada-Pérez; Maria Currás-Freixes; Juan María Roldán-Romero; Veronika Mancikova; Rocío Letón; Laura Remacha; María Santos; Nelly Burnichon; Charlotte Lussey-Lepoutre; Elena Rapizzi; Osvaldo Graña; Cristina Álvarez-Escolá; Aguirre A de Cubas; Javier Lanillos; Alfonso Cordero-Barreal; Ángel M Martínez-Montes; Alexandre Bellucci; Laurence Amar; Fabio Luiz Fernandes-Rosa; María Calatayud; Javier Aller; Cristina Lamas; Júlia Sastre-Marcos; Letizia Canu; Esther Korpershoek; Henri J Timmers; Jacques Wm Lenders; Felix Beuschlein; Martin Fassnacht-Capeller; Graeme Eisenhofer; Massimo Mannelli; Fátima Al-Shahrour; Judith Favier; Cristina Rodríguez-Antona; Alberto Cascón; Cristina Montero-Conde; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

10.  The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis.

Authors:  Mingzhu Liu; Anna Roth; Min Yu; Robert Morris; Francesca Bersani; Miguel N Rivera; Jun Lu; Toshihiro Shioda; Shobha Vasudevan; Sridhar Ramaswamy; Shyamala Maheswaran; Sven Diederichs; Daniel A Haber
Journal:  Genes Dev       Date:  2013-12-01       Impact factor: 11.361
View more
  1 in total

1.  Exosomal miR-483-5p in Bone Marrow Mesenchymal Stem Cells Promotes Malignant Progression of Multiple Myeloma by Targeting TIMP2.

Authors:  Jianmei Gu; Maoye Wang; Xinfeng Wang; Jiao Li; Haiyan Liu; Zenghua Lin; Xi Yang; Xu Zhang; Hong Liu
Journal:  Front Cell Dev Biol       Date:  2022-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.